Literature DB >> 16241145

Structural insights into the coordination and extraction of Pb(II) by disulfonamide ligands derived from o-phenylenediamine.

Robert J Alvarado1, Jay M Rosenberg, Aileen Andreu, Jeffrey C Bryan, Wei-Zhong Chen, Tong Ren, Konstantinos Kavallieratos.   

Abstract

The o-phenylenediamine-derived disulfonamide ligands 1 and 2 complex and efficiently extract Pb(II) from water into 1,2-dichloroethane via ion-exchange, in combination with 2,2'-bipyridine (97.5% and 95.0%, respectively, for 1:1 ligand-to-Pb ratios). The corresponding Pb(II)-sulfonamido binary complexes of ligands 1 and 2 (3 and 4, respectively), and ternary complexes with 2,2'-bipyridine (5 and 6, respectively), were isolated and characterized. (1)H NMR spectra of the organic phases after extraction show the formation of ternary Pb-sulfonamido-bipy complexes. X-ray characterization of 3, 4, and the ternary complex 5 consistently demonstrates four primary coordination sites and a stereochemically active lone pair on Pb. The X-ray structure of 3 shows a pseudo trigonal bipyramidal configuration on Pb, with the lone pair occupying one of the equatorial sites, and the formation of an unusual "hemidirected" coordination polymer via axial S=O-Pb coordination. The same axial S=O-Pb coordination pattern with two DMSO molecules is observed in the structure of 4.[2(CH(3))(2)SO)], thus rationalizing the high solubility of the binary complexes in strongly coordinating solvents. In contrast, the X-ray structure of the ternary complex 5 reveals a distorted four-coordinate configuration with only weak S=O-Pb coordination leading to dimer formation, thus explaining its higher solubility in weakly coordinating solvents. FT-IR spectroscopy confirms the X-ray data, since the ligand nu(S)(=)(O) stretching frequencies shift to lower values in the binary Pb(II)-sulfonamido complexes and are again altered upon formation of the ternary Pb(II)-sulfonamido-bipy complexes, as would be expected for 2,2'-bipy complexation and hindered S=O-Pb coordination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16241145     DOI: 10.1021/ic051103r

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  7 in total

1.  Investigation of disulfonamide ligands derived from o-phenylenediamine and their Pb(II) complexes by electrospray ionization mass spectrometry.

Authors:  Weihua Zhang; Yong Cai; Konstantinos Kavallieratos
Journal:  Rapid Commun Mass Spectrom       Date:  2006       Impact factor: 2.419

2.  Remote site-selective C-H activation directed by a catalytic bifunctional template.

Authors:  Zhipeng Zhang; Keita Tanaka; Jin-Quan Yu
Journal:  Nature       Date:  2017-03-08       Impact factor: 49.962

3.  Bis(benzoato-κO,O')(2,2'-bipyridine-κN,N')lead(II) benzoic acid monosolvate.

Authors:  Juan Yang; Jiantong Li
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-11-17

4.  catena-Poly[[(benzoato-κO,O')(2,2'-bipyridine-κN,N')lead(II)]-μ(3)-nitrato-κO:O,O':O''].

Authors:  Juan Yang; Jun Dai; Xiaohan Wang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-11-27

5.  Bis(benzoato-κO,O')(1,10-phenanthroline-κN,N')lead(II) benzoic acid mono-solvate.

Authors:  Jun Dai; Juan Yang; Jiantong Li
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-11-27

Review 6.  The expanding world of hybrid perovskites: materials properties and emerging applications.

Authors:  Sarah Brittman; Gede Widia Pratama Adhyaksa; Erik Christian Garnett
Journal:  MRS Commun       Date:  2015-03       Impact factor: 2.566

7.  Tuning PtII -Based Donor-Acceptor Systems through Ligand Design: Effects on Frontier Orbitals, Redox Potentials, UV/Vis/NIR Absorptions, Electrochromism, and Photocatalysis.

Authors:  Sebastian Sobottka; Maite Nößler; Andrew L Ostericher; Gunter Hermann; Noah Z Subat; Julia Beerhues; Margarethe Behr-van der Meer; Lisa Suntrup; Uta Albold; Stephan Hohloch; Jean Christophe Tremblay; Biprajit Sarkar
Journal:  Chemistry       Date:  2020-01-22       Impact factor: 5.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.